Onkologic
Ellicott City, US · Founded 2021 · Delaware corporation
OnKologic (Enable Life Sciences) develops Enable-NK cell culture media and a 10x concentrated supplement for expanding Natural Killer (NK) cells, used by NK cell research groups and in immuno-oncology cell therapy development. The products aim to improve NK cell performance metrics such as cytotoxicity, transduction efficiency, and cryopreservation for cancer research applications.
Founders & leadership
Onkologic was founded in 2021 by Rachit Ohri.
RO
Rachit OhriCEO and Founder
CG
Chandni Gupta OhriNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$305K disclosed across 1 round · 2022
▶$305KraisedJul 2022 · 12 investors · BiotechnologyRule 506(b)
▶$305KraisedJul 2022 · 12 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Chandni Gupta OhriDirector, Promoter
- Rachit OhriExecutive Officer, Director, Promoter
- Amount sold
- $305K
- Minimum investment
- $15K
- First sale
- Apr 2022
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 1
by search overlapCompanies competing with Onkologic for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Onkologic do?
- OnKologic (Enable Life Sciences) develops Enable-NK cell culture media and a 10x concentrated supplement for expanding Natural Killer (NK) cells, used by NK cell research groups and in immuno-oncology cell therapy development. The products aim to improve NK cell performance metrics such as cytotoxicity, transduction efficiency, and cryopreservation for cancer research applications.
- Who founded Onkologic?
- Onkologic was founded by Rachit Ohri in 2021.
- How much funding has Onkologic raised?
- Onkologic has disclosed $305K raised across 1 round.
- Where is Onkologic headquartered?
- Onkologic is headquartered in Ellicott City, US.
